Senior insider sale
CLO & Secretary at LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$7.32M
25K shares
What this filing means
REARDON ANDREW plans to sell 25K shares of LIGAND PHARMACEUTICALS INC valued at approximately $7.32M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/3/2026ACC: 0001950047-26-009091
Officer· CLO & Secretary
Since Mar 2026
25K
Shares to sell
$7.32M
Approx. market value
15K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months3
Exercise of Stock Options
Cash
9/3/2026
5.34KRestricted Stock Units
N/A
2/15/2025
3.34KPerformance Stock Units
N/A
2/14/2025
6.32KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/3/2026 | Exercise of Stock Options Cash | 5.34K | — |
2/15/2025 | Restricted Stock Units N/A | 3.34K | — |
2/14/2025 | Performance Stock Units N/A | 6.32K | — |
| Total | 15K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5K
Market value
$1.44M
8/3/2026
—Completed
Units to sell
5K
Market value
$1.57M
7/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
15K
Market value
$4.30M
9/3/2026
Total
Units
25K
Value
$7.32M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/3/2026 | 5K | $1.44M | — | Completed |
7/1/2026 | 5K | $1.57M | — | Completed |
| Planned — Approximate Date | ||||
9/3/2026 | 15K | $4.30M | NASDAQ | Planned |
| Total | 25K | $7.32M | ||